Cyclin E1 protein overexpression sensitizes ovarian cancer cells to ZN-c3, a novel, selective and oral bioavailable inhibitor of Wee1

被引：4
|
作者：
Ma, Jianhui
Liu, Wen
Chung, Heekyung
Izadi, Hooman
DeJong, Petrus
Harismendy, Olivier
Li, Jia
Donate, Fernando
Samatar, Ahmed
Lackner, Mark
Escoubet, Laure
Bunker, Kevin
Kim, Daehwan
Jameson, Nathan
Ozmen, Tugba Yildiran
Jeong, Kangjin
Zhang, Dong
Pan, Wen-An
Mills, Gordon
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2153
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Ginsenoside Rg3 sensitizes colon cancer cells to DNA damage reagents by inhibiting WEE1 kinase expression
    Chen Wenchao
    Zhang Xiefu
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2015, 10 (04): : 48 - 52
  • [22] WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status
    Al-Jamaei, Aisha Hussein
    de Visscher, Jan G. A. M.
    Subramanyam, V. Ramadugula
    Forouzanfar, Tymour
    Sminia, Peter
    Doulabi, Behrouz Zandieh
    Helder, Marco N.
    ORAL DISEASES, 2023, 29 (07) : 2640 - 2649
  • [23] Identifying and overcoming a mechanism of resistance to WEE1 kinase inhibitor AZD1775 in high grade serous ovarian cancer cells
    Gomez, Miriam K.
    Thomson, John P.
    Grimes, Graeme R.
    Wang, Anderson T.
    Churchman, Michael
    O'Connor, Mark J.
    Gourley, Charlie
    Melton, David W.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (02) : 183 - 195
  • [24] Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer
    Goncalves Ribeiro, Adriana Regina
    Salvadori, Marcela Marineli
    de Brot, Louise
    Bovolin, Graziele
    Mantoan, Henrique
    Ilelis, Felipe
    Rezende, Mariana
    do Amaral, Nayra Soares
    Sanches, Solange Moraes
    Lisboa Maya, Joyce Maria
    dos Santos, Elizabeth Santana
    Pereira, Ronaldo
    Castro, Fabricio de Souza
    da Nogueira Silveira Lima, Joao Paulo
    Gadelha Guimaraes, Andrea Paiva
    Baiocchi, Glauco
    Balieiro Anastacio da Costa, Alexandre Andre
    ECANCERMEDICALSCIENCE, 2021, 15
  • [25] The natural dietary phytochemical indole-3-carbinole (13C) sensitizes ovarian cancer cells to the proteasome inhibitor bortezomib through inhibition of cyclin E activity
    Taylor-Harding, Barbie
    Orsulic, Sandra
    Miller, Carl
    Berenson, James R.
    Karlan, Beth
    Walsh, Christine
    CANCER RESEARCH, 2010, 70
  • [26] miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O
    Chen, Binghai
    Duan, Lujing
    Yin, Guangming
    Tan, Jing
    Jiang, Xianzhen
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (04) : 229 - 238
  • [27] LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein
    Cai, Zijie
    Shi, Qianfeng
    Li, Yudong
    Jin, Liang
    Li, Shunying
    Wong, Lok Lam
    Wang, Jingru
    Jiang, Xiaoting
    Zhu, Mengdi
    Lin, Jinna
    Wang, Qi
    Yang, Wang
    Liu, Yujie
    Zhang, Jun
    Gong, Chang
    Yao, Herui
    Yao, Yandan
    Liu, Qiang
    SCIENCE ADVANCES, 2023, 9 (40)
  • [28] Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
    Roering, Pia
    Siddiqui, Arafat
    Heuser, Vanina D.
    Potdar, Swapnil
    Mikkonen, Piia
    Oikkonen, Jaana
    Li, Yilin
    Pikkusaari, Sanna
    Wennerberg, Krister
    Hynninen, Johanna
    Grenman, Seija
    Huhtinen, Kaisa
    Auranen, Annika
    Carpen, Olli
    Kaipio, Katja
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] A novel ALDH1A selective inhibitor induces necroptosis in ovarian cancer stem -like cells
    Chefetz-Menaker, Ilana
    Yang, Kun
    Buckanovich, Ron
    CANCER RESEARCH, 2016, 76
  • [30] The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP ribose polymerase inhibitors via E2F1 downregulation.
    Wilson, Andrew J.
    Saskowski, Jeanette
    Khabele, Dineo
    CLINICAL CANCER RESEARCH, 2016, 22
12345